NeISS research pathways, impact and outreach meeting with Meik Poschen
Develop 'a paragraph or a few sentences' about the work Tom and I have been doing in NeISS focussing on the research pathways, impact and outreach.
There have been many organisations sort of involved in and that have supported the work Tom and I have been doing. I think it is fair to badge the main supporters (in addition to JISC) as GENESIS (ESRC) and GridPP.
The demographic model development work was largely GENESIS work. In NeISS we have refactored the code so that the programs will run as part of a 'Genesis Simulator' that uses GridPP site data storage and compute elements. We have tested that the system works and have produced individual level demographic simulation results for Leeds. These we still regard as 'test results' and they were presented with details of the e-Infrastructure at the UK e-Science All Hands Meeting in September 2012. The paper was reworked and submitted for the special issue of the Royal Philosophical Transactions A and we are currently awaiting peer review feedback.
The GENESIS model is designed to input data in a standard XML format and can produce simulation results for any place so long as the data is prepared according to the schemas for the XML. For UK runs, we use Census data inputs and ONS Vital Statistics to generate the Population, Mortality, Fertility and Miscarriage probability data.
We are currently making some changes to enhance the model and outputs and are preparing data to generate simulation results for England from 1981 to 2011. We hope that these results will be of more interest to Demographic Modellers (than the results we have produced for Leeds). As yet the demographic modellers we have tried to engage with have found it curious that we are attempting to model at a daily time step and they seem sceptical that this can be done and that the results will be interesting or useful.
Looking forward, we are planning to submit a proposal to the ESRC Secondary Data Analysis Call and to gear the models to look specifically at health. We aim to reach further to link with epidemiology and health care planning in this next phase. We are still building our pathways to impact, but we believe that there is much potential in this direction.